Home › Juvenile Arthritis › Utah › Salt Lake City
Juvenile Arthritis clinical trials in Salt Lake City, UT
4 studies for Juvenile Arthritis are looking for participants at sites in and around Salt Lake City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
RecruitingPhase 1
- University of Utah, Salt Lake City
A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease
RecruitingPhase 2
- University of Utah, Salt Lake City
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
RecruitingPhase 3
- University of Utah, Salt Lake City
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
RecruitingObservational study
- University of Utah Hospitals and Clinics (Primary Children's Hospital), Salt Lake City
About Juvenile Arthritis
Juvenile arthritis or JA, causes joint swelling, pain, stiffness and loss of motion in children. Learn diagnosis and tests for JA.
More about Juvenile Arthritis on MedlinePlus
Juvenile Arthritis trials in other cities
- Washington, DC6 studies
- Cincinnati, OH6 studies
- Portland, OR5 studies
- New York City, NY4 studies
- Pittsburgh, PA4 studies
- Gainesville, FL3 studies
- Indianapolis, IN3 studies
- Cleveland, OH3 studies
Other studies in Salt Lake City
- Non-Small Cell Lung Cancer31 studies
- Cancer (all types)27 studies
- Breast Cancer27 studies
- Colorectal Cancer22 studies
- Lung Cancer21 studies
- Melanoma21 studies
- Multiple Myeloma21 studies
- Metastatic Cancer20 studies
- Ovarian Cancer19 studies
- Obesity18 studies
- Acute Myeloid Leukemia17 studies
- Heart Failure17 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.